Why Phathom Pharmaceuticals (PHAT) Is Up 13.2% After Guiding To 2026 Operating Profitability And Narrower Losses [Yahoo! Finance]
Phathom Pharmaceuticals, Inc. (PHAT)
Last phathom pharmaceuticals, inc. earnings: 3/19 08:31 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
earlier, with full-year loss improving to US$221.25 million from US$334.33 million and basic loss per share falling to US$0.29 for the quarter and US$3.03 for the year. Alongside these results, management issued 2026 guidance calling for US$320 million to US$345 million in net revenues and expecting operating profitability, excluding stock-based compensation, to begin in the third quarter and extend across the full year as certain third-party charges shift into cost of goods sold. We'll now examine how Phathom's expectation of achieving operating profitability in 2026 reshapes its existing investment narrative and risk balance. This technology could replace computers: discover 23 stocks that are working to make quantum computing a reality Phathom Pharmaceuticals Investment Narrative Recap To own Phathom, you need to believe VOQUEZNA can sustain meaningful U.S. uptake long enough for the company to transition from heavy investment to self-funded growth. The latest results and
Show less
Read more
Impact Snapshot
Event Time:
PHAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PHAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PHAT alerts
High impacting Phathom Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
PHAT
News
- Guggenheim Raises PT on Phathom Pharmaceuticals (PHAT) to $25 From $20, Here's Why [Yahoo! Finance]Yahoo! Finance
- Phathom Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Phathom Pharmaceuticals (PHAT) had its price target raised by Guggenheim from $20.00 to $25.00. They now have a "buy" rating on the stock.MarketBeat
- Phathom Pharmaceuticals (PHAT) was given a new $28.00 price target by Stifel Nicolaus.MarketBeat
- Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance [Yahoo! Finance]Yahoo! Finance
PHAT
Earnings
- 2/26/26 - Beat
PHAT
Sec Filings
- 3/3/26 - Form 4
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- PHAT's page on the SEC website